Factors associated with adherence to oral antihyperglycemic monotherapy in patients with type 2 diabetes

Factors associated with adherence to oral antihyperglycemic monotherapy in patients with type 2 diabetes

Kaan Tunceli,1 Changgeng Zhao,1 Michael J Davies,2 Kimberly G Brodovicz,3 Charles M Alexander,4 Kristy Iglay,1 Larry Radican1 1Global Health Outcomes, Merck & Co, Inc, Whitehouse Station, NJ, USA; 2Global Scientific and Medical Publications, Merck & Co, Inc, Whitehouse Station, NJ, U...

Full description

Bibliographic Details
Main Authors:	Tunceli K, Zhao C, Davies MJ, Brodovicz KG, Alexander CM, Iglay K, Radican L
Format:	Article
Language:	English
Published:	Dove Medical Press 2015-01-01
Series:	Patient Preference and Adherence
Online Access:	http://www.dovepress.com/factors-associated-with-adherence-to-oral-antihyperglycemic-monotherap-peer-reviewed-article-PPA

Similar Items

Effect of pill burden on dosing preferences, willingness to pay, and likely adherence among patients with type 2 diabetes
by: Hauber AB, et al.
Published: (2013-09-01)

Assessment of severity and frequency of self-reported hypoglycemia on quality of life in patients with type 2 diabetes treated with oral antihyperglycemic agents: A survey study
by: Radican Larry, et al.
Published: (2011-07-01)

Secondary metformin monotherapy failure in individuals with type 2 diabetes mellitus
by: Lingfeng Yang, et al.
Published: (2021-08-01)

The Association between Adherence to Oral Antihyperglycemic Agent and HbA1c Level
by: Indana Ayu Soraya, et al.
Published: (2022-08-01)

TYPE 2 DIABETES: ASPECTS OF ANTIHYPERGLYCEMIC THERAPY IN ELDERLY PATIENTS
by: Mokhort T.V., et al.
Published: (2019-03-01)

ANTIHYPERGLYCEMIC THERAPY FOR PATIENTS WITH DIABETES MELLITUS TYPE 2
by: Е. E. Tomina
Published: (2013-12-01)

Dyslipidemia: The untreated metabolic dysfunction in people with type 2 diabetes in Latin America. ARETAEUS study outcomes
by: Juan José Gagliardino, et al.
Published: (2019-03-01)

Effect of oral antihyperglycemic drugs on purine metabolism
by: T. S. Panevin
Published: (2021-11-01)

Adherence to antihyperglycemic medications and glucagon-like peptide 1-receptor agonists in type 2 diabetes: clinical consequences and strategies for improvement
by: Giorgino F, et al.
Published: (2018-05-01)

Modern antihyperglycemic agents prescribed in Russia for type 2 diabetes mellitus
by: Yury Ivanovich Suntsov
Published: (2012-03-01)

Management of type 2 diabetes mellitus: selecting the right of antihyperglycemic medication
by: E. V. Biryukova
Published: (2018-03-01)

Real-world Observational Study on Patient Outcomes in Diabetes (RESPOND): study design and baseline characteristics of patients with type 2 diabetes newly initiating oral antidiabetic drug monotherapy in Japan
by: Daisuke Yabe, et al.
Published: (2020-12-01)

Analysis of Patents Issued in China for Antihyperglycemic Therapies for Type 2 Diabetes Mellitus
by: Wei Zhu, et al.
Published: (2019-05-01)

Study of the Association Between Antihyperglycemic Therapy and Cancer in Patients with Type 2 Diabetes Mellitus
by: Tamara Vatseba, et al.
Published: (2020-09-01)

Frequency of cardiovascular complications in patients with type 2 diabetes mellitus depending on antihyperglycemic therapy
by: Z.G. Krushinska, et al.
Published: (2018-09-01)

FEATURES OF ANTIHYPERGLYCEMIC THERAPY IN PATIENTS WITH TYPE 2 DIABETES IN COMBINATION WITH OBSTRUCTIVE SLEEP APNEA
by: I. P. Dаrаshkevich, et al.
Published: (2020-08-01)

Type 2 diabetes mellitus and chronic kidney disease: modern opportunities for antihyperglycemic therapy
by: O.M. Didushko
Published: (2020-04-01)

Combined Therapy with Antihyperglycemic Oral Agents (Metformin, Sulfonylureas) and Insulin in the Management of Type 2 Diabetic Patients (Pathogenic Substantiation and Clinical Utility)
by: M.Yu. Horshunskaia
Published: (2015-05-01)

The impact of currently used oral antihyperglycemic drugs on dysfunctional adipose tissue
by: Tomić-Naglić Dragana, et al.
Published: (2017-01-01)

Antihyperglycemic activity of Caralluma quadrangula in streptozotocin-induced diabetic rats
by: Essam Abdel-Sattar, et al.
Published: (2017-12-01)

Antihyperglycemic and hepatoprotective effects of Salvia tebesana Bunge in diabetic rats
by: Hamed Aramjoo, et al.
Published: (2022-01-01)

Antihyperglycemic and Antihyperlipidemic Effect of Chronic Administration of Hesperetin in Diabetic Rats
by: M Roghani, et al.
Published: (2010-10-01)

Comparative pharmacoepidemiological study of antihyperglycemic drugs utilization by patients with type 2 diabetes mellitus in Moscow
by: Marina F. Kalashnikova, et al.
Published: (2016-07-01)

Monotherapy in Patients with Type 2 Diabetes Mellitus
by: Sang Youl Rhee, et al.
Published: (2017-10-01)

Real-World Adherence and Discontinuation of Glucagon-Like Peptide-1 Receptor Agonists Therapy in Type 2 Diabetes Mellitus Patients in the United States
by: Weiss T, et al.
Published: (2020-11-01)

Antihyperglycemic activity of colostrum peptides
by: Sergei L. Tikhonov, et al.
Published: (2024-01-01)

Interactions between Gut Microbiota and Oral Antihyperglycemic Drugs: A Systematic Review
by: Nicoleta Mihaela Mindrescu, et al.
Published: (2024-03-01)

Effects of diabetes compensation by various classes of antihyperglycemic agents on endovascular intervention outcomes in patients with type 2 diabetes mellitus
by: Marina Sergeevna Michurova, et al.
Published: (2014-03-01)

Contemporary National Patterns of Eligibility and Use of Novel Cardioprotective Antihyperglycemic Agents in Type 2 Diabetes Mellitus
by: Arash A. Nargesi, et al.
Published: (2021-07-01)

Effect of Antihyperglycemic Agents on Hemoglobin A1c Level in Type 2 Diabetes Mellitus Patients
by: Tasya Kamila, et al.
Published: (2018-06-01)

Antihyperglycemic and antioxidative effects of Lygodium microphyllum in alloxan induced diabetic rats
by: D.G. Syahidah Nadiah binti Abdull Majid, et al.
Published: (2018)

Evaluation of antihyperglycemic and antihyperlipidemic potential of Nelumbo nucifera seeds in diabetic rats
by: Shahnaz,, et al.
Published: (2016)

Association of Antihyperglycemic Therapy with Risk of Atrial Fibrillation and Stroke in Diabetic Patients
by: Cristina-Mihaela Lăcătușu, et al.
Published: (2019-09-01)

Antihyperglycemic and diabetic wound healing activity of smallanthus sonchifolius leaves extract
by: Herowati Rina, et al.
Published: (2018-01-01)

Evaluation of the Association of CGM Metrics with Antihyperglycemic Drugs in Insulin-Treated Diabetics
by: Toshiyuki Horiuchi, et al.
Published: (2021-10-01)

Traditional multi-herbal formula in diabetes therapy – Antihyperglycemic and antioxidant potential
by: Nebojša Salaj, et al.
Published: (2021-10-01)

Antihyperglycemic activity of the bark methanolic extract of Syzygium mundagam in diabetic rats
by: Rahul Chandran, et al.
Published: (2017-12-01)

Hypoglycemia: a review of definitions used in clinical trials evaluating antihyperglycemic drugs for diabetes
by: Balijepalli C, et al.
Published: (2017-05-01)

Initiation and intensification of antihyperglycemic therapy in type 2 diabetes mellitus: Update of Russian Association of Endocrinologists expert consensus document (2015)
by: Ivan Ivanovich Dedov, et al.
Published: (2015-03-01)

Hypoglycemia in patients with type 2 diabetes treated with oral antihyperglycemic agents detected by continuous glucose monitoring: a multi-center prospective observational study in Croatia
by: Maja Baretić, et al.
Published: (2020-03-01)